Found vs MangoRx: Which GLP-1 Provider Is Better?

By Iacob Pastina, Independent Researcher

52 providers verified independently·Independent research·How we rank →

MangoRx beats Found overall, scoring 7.5/10 vs 7.3/10. Found is more affordable at $129/mo vs $299/mo. Choose Found for insured patients who want their glp-1 coverage checked and t. Choose MangoRx for needle-phobic users who want oral-only glp-1 tablets from a .

A side-by-side look at Found and MangoRx to help you decide. We compare them on:

•Starting price per month
•Our overall score, out of 10
•Medication type, brand-name or compounded
•Whether they accept insurance
•Who each one is best for

Found

#36 of 52

7.3/10

Science-backed weight management platform combining GLP-1 medications with behavioral health coaching and support.

Visit Found

Higher Rated

MangoRx

#26 of 52

7.5/10

Multi-service telehealth platform offering compounded GLP-1 alongside other health services.

Visit MangoRx

Feature	Found	MangoRx
Our Score	7.3/10	7.5/10
Starting Price	$129/mo	$299/mo
Medication Type	Both	Compounded
Insurance Accepted	Yes	No
Best For	Insured patients who want their GLP-1 coverage checked and their copay minimized	Needle-phobic users who want oral-only GLP-1 tablets from a publicly traded company
Ranking	#36	#26
Get started	Visit Found	Visit MangoRx

Pros & Cons Compared

Found

Pros

+Active insurance coordination, Found contacts your insurer and reports which GLP-1s are covered, prior auth requirements, and estimated copay
+10+ medication options including both compounded and brand-name (Wegovy, Zepbound, Wegovy pill), the widest formulary of any platform
+Typical insured copay of ~$30/mo for most members, dramatically lower than cash-pay alternatives
+Most members start treatment within one week of completing the health questionnaire

Cons

−Costs vary by insurance status and medication choice rather than one flat rate; run Found's coverage check first to see your exact copay before paying
−The insurance navigation process adds steps compared to simple cash-pay platforms; the payoff is the ~$30 typical copay
−Compounded medication availability may shift with FDA enforcement changes; the 10+ medication formulary lets your clinician move you to a brand-name option if it does

MangoRx

Pros

+Oral dissolving tablets exclusively, zero injections for any GLP-1 option
+Publicly traded on NASDAQ (MGRX), SEC-required financial transparency that private competitors can't match
+Semaglutide tablet includes Vitamin B6 to help reduce nausea during treatment
+Free 100% online consultation with no video call required

Cons

−Oral semaglutide at $299/mo runs 2-3x injectable alternatives ($99-149/mo). The premium only makes sense if needles are a hard no for you.
−Early-stage public company with limited revenue; the same SEC filings that provide transparency also show the financial uncertainty reflected in the stock.
−Oral tablets are the only format, with no injectable option if you want higher bioavailability. If you may switch to injections later, pick a platform that carries both.

Our Verdict

MangoRx edges out Found with a score of 7.5/10 vs 7.3/10. If budget is your priority, Found starts at $129/mo compared to MangoRx's $299/mo. Found accepts insurance, which can significantly reduce your out-of-pocket costs. Found offers both brand-name and compounded medications, giving you more flexibility. Choose Found if you want: insured patients who want their glp-1 coverage checked and their copay minimized. Choose MangoRx if you want: needle-phobic users who want oral-only glp-1 tablets from a publicly traded company.

Still undecided? Editor's Featured Pick

Yucca Health

$146/mo · 7.7/10 · Compounded

If neither Found nor MangoRx feels like the right fit, our featured pick across all 52 GLP-1 telehealth providers is Yucca Health. It is not the highest-scored provider in our full rankings. We feature it for its low-friction value: a flat $146/mo that stays the same at every dose.

Visit Yucca Health→Read our full Yucca Health review